Medications Development for the Treatment of Cannabis Related Disorders

Summary

The primary objective of this application is to test the neurobehavioral mechanisms and effects of aprepitant as a new cessation agent for cannabis, tobacco or both.

Timeline

Start

2009-08

Primary completion

2012-01

Completion

2012-04

Publications

• Gunderson EW, Haughey HM, Ait-Daoud N, Joshi AS, Hart CL. A survey of synthetic cannabinoid consumption by current cannabis users. Subst Abus. 2014;35(2):184-9. doi: 10.1080/08897077.2013.846288.

Drugs

Indications